Thus, SIK activity seems relevant in still other immune system compartments, including mast cell IL-33 cytokine release [35], and it even modulates adaptive immunity through the regulation of T-cell lineage commitment, differentiation, and survival [36,37], therefore offering a multitude of potential indirect mechanisms to exert MT therapeutic effects in FM. Here, IL33 is linked to cancer.